BURBANK, Calif., Nov. 19, 2021 (GLOBE NEWSWIRE) — by way of NewMediaWire – Medolife Rx, Inc. (“Medolife”), a world built-in bioceutical firm with R&D, manufacturing, and shopper product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTCQB: QNTA), introduced right this moment that it has scheduled a convention name with traders for Tuesday, November twenty third.
Convention Name Subjects:
- Bi-annual go to and submitting with Ministry of Atmosphere;
- Tony Hawk advert marketing campaign;
- 257% enhance in efficacy of Ibuprofen utilizing proprietary polarization method from inside research;
- Replace on comparative research on CBD muscle rub, which confirmed a big efficacy enhance attributable to polarization expertise;
- Replace on progress with the federal government of the Dominican Republic;
- Replace on FINRA on the title and image change;
- Replace on the AELIA comparative research;
- Replace on Mexico distribution;
- Replace on social media gross sales packages;
- Replace on large field retailer conversations;
- New enterprise verticals, comparable to polarized ribosomes.
“The third quarter was uniquely essential for Medolife as we continued to focus each on our relationship with the federal government of the Dominican Republic and monetizing the Escozine product line, in addition to on rising gross sales of our shopper Aelia product strains,” stated Medolife CEO Dr. Arthur Mikaelian. “As a full-scale life sciences firm, navigating the regulatory frameworks of each the pharmaceutical and nutraceutical industries is difficult and time consuming. That stated, I couldn’t be prouder of how far we’ve got are available in such a short while. We’re on the precipice of a take care of the DR that might dramatically expedite the expansion of our Escozine product line and open up new channels of distribution, enabling us to carry these medically useful merchandise to sufferers globally. Moreover, our Aelia product line continues to see an ideal response from shoppers, and we stay assured on our place with the FDA in our PIND submitting. All in all, we’re extraordinarily assured about the way forward for Medolife.”
“We’ve all the time strived for transparency and open communication with our present and potential traders. That’s the reason we will likely be internet hosting a convention name subsequent week. We plan to debate the third quarter, present updates on the assorted points of the corporate, and tackle questions as a lot as potential. We encourage our shareholders to attend, and we sit up for the chance,” added Mikaelian.
Dr. Mikaelian and Quanta, Inc. acting-CFO Clemente Pascarella will maintain a convention name with the funding group on Tuesday, November 23, at 5 p.m. Japanese Commonplace Time. They may current on the Firm’s milestones achieved within the quarter, in addition to the long run positioning of the Firm. Moreover, the 2 will take questions from the funding group on the finish of the decision.
To register for this name, please use the beneath net hyperlink: https://us06web.zoom.us/webinar/register/WN_FDQO-lDCTQ2TrwtTgdAdTQ
You probably have questions, please ship an electronic mail to medolife@cmwmedia.com with ‘QNTA Query’ within the topic line by NOON Japanese Daylight Time on Monday, November 22. Administration will reply as many questions as time will enable. For these unable to take part within the reside webcast, an archived model of the webcast will likely be accessible within the following days.
About Medolife Rx
Medolife Rx, Inc. is a world biotechnology firm with operations in scientific analysis, manufacturing, and shopper merchandise. Medolife Rx was created by the merger of Medolife, a non-public firm based by Dr. Arthur Mikaelian who pioneered the unlaying polarization expertise that makes the Firm’s portfolio of pharmaceutical and nutraceutical merchandise so efficient, and Quanta, Inc., a direct-to-consumer wellness product portfolio firm. The Firm’s lead scientific improvement packages embody Escozine® ®, a proprietary formulation consisting of small molecule peptides derived from Rhopalurus princeps scorpions, which is amplified by the Firm’s polarization expertise and is being researched as a therapy of assorted indications, together with COVID-19 and most cancers. The Firm has accomplished preclinical security and efficacy analysis on Escozine® ® and is pursuing product registration and drug approval in numerous international locations, together with america and all through Latin America.
Via its subsidiary AELIA, Medolife manufactures and distributes shopper wellness merchandise in high-impact shopper areas comparable to ache reduction, magnificence, and common wellness. AELIA merchandise are designed utilizing Dr. Mikaelian’s polarization expertise, which applies advances in quantum biology to extend the efficiency of energetic components. Finally, Quanta’s mission is to ship higher, more practical components to raise product efficacy, scale back waste, and facilitate more healthy, extra sustainable consumption.
Past its personal scientific and shopper purposes, the polarization expertise utilized by Medolife and its subsidiaries has many potential purposes. From potentiating bio-ingredients, to producing more-effective carbon-trapping crops, to transformative anti-aging options, Medolife has the chance to upend how industrial and pharmaceutical merchandise are made and enhance their advantages, whereas reducing their chemical focus.
Ahead-Trying Statements
Secure Harbor Assertion underneath the U.S. Personal Securities Litigation Reform Act of 1995: This launch incorporates statements which might be forward-looking in nature which specific the beliefs and expectations of administration together with statements concerning the Firm’s anticipated outcomes of operations or liquidity; statements regarding projections, predictions, expectations, estimates or forecasts as to our enterprise, monetary and operational outcomes and future financial efficiency; and statements of administration’s objectives and aims and different comparable expressions regarding issues that aren’t historic details. In some circumstances, you may determine forward-looking statements by terminology comparable to “anticipate,” “estimate,” “plan,” “undertaking,” “persevering with,” “ongoing,” “anticipate,” “we consider,” “we intend,” “might,” “will,” “ought to,” “might,” and comparable expressions. Such statements are primarily based on present plans, estimates and expectations and contain a lot of identified and unknown dangers, uncertainties and different elements that would trigger the Firm’s future outcomes, efficiency or achievements to vary considerably from the outcomes, efficiency or achievements expressed or implied by such forward-looking statements. These elements and extra info are mentioned within the Firm’s filings with the Securities and Change Fee and statements on this launch ought to be evaluated in mild of those essential elements. Though we consider that these statements are primarily based upon cheap assumptions, we can not assure future outcomes. Ahead-looking statements converse solely as of the date on which they’re made, and the Firm undertakes no obligation to replace publicly or revise any forward-looking assertion, whether or not because of new info, future developments or in any other case.
Contacts:
ir@medoliferx.com
